ABNB three-lens brief
Evidence-based stock research on ABNB. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 8.0pp over 30 days. · Debt-to-equity of 33.2 — balance-sheet-heavy.
- Underperforming SPY by 8.0pp over 30 days.
- Analyst mean target $156.18 — 17% above current (36 analysts).
- Debt-to-equity of 33.2 — balance-sheet-heavy.
- Reported earnings on 2026-05-07.
ABNB closed at $133.00 (-1.83%) as of 2026-05-13. Market cap: $78.93B. P/E (trailing) 32.8. Positives: analyst mean target $156.18 — 17% above current (36 analysts).. Concerns: underperforming SPY by 8.0pp over 30 days.; debt-to-equity of 33.2 — balance-sheet-heavy.. Last quarter: Revenue $2.68B, net income $160.00M, free cash flow $3.19B.
Why three lenses on ABNB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABNBacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ABNB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABNB brief"></iframe>